Atea Pharmaceuticals (AVIR) Change in Cash: 2018-2024
Historic Change in Cash for Atea Pharmaceuticals (AVIR) over the last 7 years, with Dec 2024 value amounting to -$79.1 million.
- Atea Pharmaceuticals' Change in Cash rose 115.86% to $11.9 million in Q4 2022 from the same period last year, while for Dec 2022 it was -$576.0 million, marking a year-over-year decrease of 573.36%. This contributed to the annual value of -$79.1 million for FY2024, which is 76.48% down from last year.
- According to the latest figures from FY2024, Atea Pharmaceuticals' Change in Cash is -$79.1 million, which was down 76.48% from -$44.8 million recorded in FY2023.
- Atea Pharmaceuticals' 5-year Change in Cash high stood at $828.5 million for FY2020, and its period low was -$576.0 million during FY2022.
- Over the past 3 years, Atea Pharmaceuticals' median Change in Cash value was -$79.1 million (recorded in 2024), while the average stood at -$233.3 million.
- As far as peak fluctuations go, Atea Pharmaceuticals' Change in Cash spiked by 6,556.68% in 2020, and later tumbled by 573.36% in 2022.
- Over the past 5 years, Atea Pharmaceuticals' Change in Cash (Yearly) stood at $828.5 million in 2020, then tumbled by 110.33% to -$85.5 million in 2021, then tumbled by 573.36% to -$576.0 million in 2022, then soared by 92.22% to -$44.8 million in 2023, then slumped by 76.48% to -$79.1 million in 2024.